Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.

MLA

Nag, Abhishek, et al. “Human Genetics Uncovers MAP3K15 as an Obesity-Independent Therapeutic Target for Diabetes.” Science Advances, vol. 8, no. 46, Nov. 2022, p. eadd5430. EBSCOhost, https://doi.org/10.1126/sciadv.add5430.

APA

Nag, A., Dhindsa, R. S., Mitchell, J., Vasavda, C., Harper, A. R., Vitsios, D., Ahnmark, A., Bilican, B., Madeyski-Bengtson, K., Zarrouki, B., Zoghbi, A. W., Wang, Q., Smith, K. R., Alegre-Díaz, J., Kuri-Morales, P., Berumen, J., Tapia-Conyer, R., Emberson, J., Torres, J. M., … Petrovski, S. (2022). Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Science Advances, 8(46), eadd5430. https://doi.org/10.1126/sciadv.add5430

Chicago

Nag, Abhishek, Ryan S Dhindsa, Jonathan Mitchell, Chirag Vasavda, Andrew R Harper, Dimitrios Vitsios, Andrea Ahnmark, et al. 2022. “Human Genetics Uncovers MAP3K15 as an Obesity-Independent Therapeutic Target for Diabetes.” Science Advances 8 (46): eadd5430. doi:10.1126/sciadv.add5430.